Microbiome field

Magical Microbes

LNC Therapeutics is developing therapies that utilize the power of the human microbiome to modulate clinically relevant pathways in multiple disease states.

The human gut microbiome is immensely diverse. The healthy gut hosts millions of microorganisms made of hundreds of species. Today it is well established that the gut microbiome executes functions that are absolutely required to maintain health.

 

2 Major Initiatives

To better understand the human microbiome, large human studies have been initiated since 2008, such as the NIH Human Microbiome Project (launched by the USNational Institutes of Health), the American and British Gut Projects, the EU’s MetaHIT (METAgenomics of the Human Intestinal Tract), MyNewGut Project and the Flemish Gut Flora Project.

The overall mission of the Human Microbiome Project is to generate resources to facilitate characterization of the human microbiota to further our understanding of how the microbiome impacts human health and disease. The project is currently in its second phase, known as iHMP, which will create integrated longitudinal datasets from both the microbiome and host from three different cohort studies of microbiome-associated conditions using multiple ‘omics technologies.

Each of these study groups has engaged in providing new computational tools and integrative molecular perspectives on microbial activity during dysbiosis. As a result of creating these multi’omic data resources, the iHMP has opened up new opportunities for data integration in the human microbiome.

more +

MetaHIT is a project financed by the European Commission, the central objective of which is to establish associations between the genes of the human intestinal microbiota and our health and disease. MetaHIT focuses on two disorders that are increasingly prevalent in Europe: inflammatory bowel disease (IBD) and obesity.

Our Microbiome is a unique fingerprint 

Global Human Microbiome Market is projected to reach USD 1,731 million in 2027

 

The growth of the human microbiome market is largely driven by the increasing focus on the development of human microbiome therapy.

Human Microbiome Market (by region, USD million) 
Source: Human Microbiome Therapeutics report (MarketsandMarkets)

Microbiome & us
News
Apr 15, 2020
LNC Therapeutics announces the acquisition of an exclusive worldwide license on the first patent related to...
> more
Mar 12, 2020
LNC Therapeutics Announces Successful GMP Manufacturing of Xla1 for Phase 1 Clinical Trial | By finalizing the...
> more
Press / Media
Nov 12, 2019
Biotechs investments disrupt Big Pharma business model The pharmaceutical industry is in a state of flux, with...
> more
Sep 6, 2019
Chaque semaine, Maddyness dresse le bilan des levées de fonds de la semaine qui vient de s’écouler. Cette semaine,...
> more
Publications
Apr 22, 2020
Keystone gut bacteria are the foundation of the whole microbial ecosystem because they provide very specific metabolic...
> more
Dec 6, 2019
The term “microbiome” refers to the collection of microorganisms (or microbiota) – including bacteria, viruses and...
> more
now on twitter
LNC Therapeutics

“Mathematical models also show that this microbial risk signature consisting of arrhythmic bacteria helps diagnosin… t.co/gkTiZ3GNpW

LNC Therapeutics © 2020 - all rights reserved terms and conditions